OSUR · Orasure Technologies Inc
Market Cap
$240.01M
Shares
68.97M
OSUR metrics
68 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$3.48
Market cap
$240.01M
Price action
19 metricsPrice change (1W)
-3.3%
Price change (30D)
-13.0%
Price change (3M)
-13.9%
Price change (6M)
+9.1%
Price change (YTD)
+43.8%
Price change (1Y)
+10.5%
Trailing year
Price change (5Y)
-68.9%
52-week high
$4.50
52-week low
$2.11
Change from 52-week high
-22.7%
Change from 52-week low
+64.9%
Annualized volatility
46.1%
Beta
1.1
RSI (14D)
34.3
Price vs SMA 50
-12.5%
Price vs SMA 200
+6.9%
Avg volume (3M)
487,096
Relative volume
0.6
Average dollar volume
$1.99M
Company
3 metricsSector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
68.97M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.1×
reciprocal yield 46.8%
P / book
0.8
reciprocal yield 132.4%
FCF yield
-20.0%
TTM · current market cap
Buyback yield
7.1%
P / FCF
—
P / operating cash flow
—
Earnings yield
-20.5%
Historical valuation
8 metricsP / E historical average (3Y)
14.9×
reciprocal yield 6.7%
P / E historical average (5Y)
24.1×
reciprocal yield 4.2%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
7.1%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-05
Profitability
9 metricsGross margin
42.6%
Operating margin
-48.1%
Trailing 12 months
Net margin
-43.7%
Gross profit (TTM)
$47.86M
Operating profit (TTM)
−$54.02M
Net income (TTM)
−$49.13M
Trailing 12 months
Diluted EPS (TTM)
$-0.70
FCF margin
-42.8%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-1.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$112.41M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-5.9%
Year over year · fewer shares
Revenue CAGR (3Y)
-33.3%
Revenue CAGR (5Y)
-7.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-15.5%
Return on assets
-13.6%
Debt / equity
—
Current ratio
8.9
EBITDA (TTM)
−$44.45M
Free cash flow (TTM)
−$48.06M
Quick ratio
7.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$160.58M
Total assets
$360.55M
Total debt
$7.04M
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$42.88M
Capital expenditures (TTM)
$5.18M
R&D (TTM)
$44.62M
SG&A (TTM)
—
Stock compensation (TTM)
$9.35M
R&D / revenue
39.7%
Stock compensation / revenue
8.3%
Ownership (13F)
3 metrics13F filers
153
13F filer change QoQ
+10
Institutional ownership
80.0%
Short interest
3 metricsShort interest
4.6%
Latest settlement · 6.1 days to cover
Days to cover
6.1d
Short-squeeze score
57 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—